The search results focus on recombinant outer membrane proteins (OMPs) and ribosomal proteins used in vaccine development, including:
L7/L12 (ribosomal protein)
OMP16, OMP19, OMP28 (outer membrane proteins)
These proteins are extensively studied for their roles in:
Immune response modulation (e.g., inducing Th1 cytokines like IFN-γ)
Vaccine efficacy (e.g., combined subunit vaccines outperforming single-protein vaccines)
The Brucella Genome Data resource lists genomic and proteomic data for Brucella abortus strains, including:
NCBI Taxon IDs (e.g., 1104320 for B. abortus A13334)
Chromosome sequences (e.g., NC_016795.1 for chromosome 1)
Protein tables and 3D structures
Nomenclature Variability
UPF0283 may refer to a hypothetical protein family (UPF = Uncharacterized Protein Family), but no studies in the provided sources link this family to B. abortus membrane proteins.
The gene identifier BAbS19_I09770 could correspond to a locus in B. abortus S19, but no functional data are available in the provided literature.
Focus on Characterized Proteins
Research emphasizes experimentally validated proteins (e.g., OMPs, L7/L12) with demonstrated roles in pathogenesis or immunity, rather than uncharacterized proteins like UPF0283 .
Databases vs. Literature
While genomic databases list uncharacterized proteins, the provided studies prioritize functional characterization of proteins with established roles in immunity or vaccine development.
To address gaps in knowledge about UPF0283/BAbS19_I09770:
Consult Specialized Databases
Uniprot: Search for "BAbS19_I09770" or "UPF0283" to identify potential homologs or annotations.
NCBI Protein Database: Use BLAST to align the sequence with B. abortus proteomes.
Review Recent Publications
The provided sources include studies up to 2022 . Check newer literature for:
Structural studies (e.g., X-ray crystallography)
Functional assays (e.g., subcellular localization, interaction partners)
Experimental Validation
If the protein is hypothesized to have a role in membrane integrity or virulence, conduct:
Gene knockout studies in B. abortus
Antigenicity testing with patient serum or immune cells
KEGG: bmc:BAbS19_I09770
STRING: 430066.BAbS19_I09770
BAbS19_I09770 is an outer membrane protein found in Brucella abortus, a Gram-negative, nonencapsulated, nonmotile, facultatively intracellular coccobacillus that causes brucellosis, a zoonotic disease transmitted from animals to humans . This protein belongs to the UPF0283 family of uncharacterized membrane proteins and spans amino acids 1-357 of its sequence . As a membrane protein, it likely contributes to cellular structure, nutrient transport, and potentially to virulence mechanisms during host infection.
Methodological approach for identification: Researchers can confirm protein identity through genomic sequence analysis of Brucella abortus strains, followed by proteomic validation using mass spectrometry and Western blotting with specific antibodies against BAbS19_I09770.
Based on established membrane protein classification systems for Brucella abortus, BAbS19_I09770 would be analyzed in relation to the three major groups of outer membrane proteins previously characterized:
Group 1: Minor components with molecular weight bands around 94,000 Da that exhibit heat modifiability
Group 2: Putative porins that appear as trimers in native state with molecular weights of 43,000 and 41,000 Da after denaturation
Group 3: Proteins producing 30,000 Da bands on SDS-PAGE, antigenically distinct from Group 2 proteins
Methodological approach for classification: Researchers should isolate the protein through sequential extraction with N-lauroylsarcosinate and dipolar ionic detergent following lysozyme predigestion . Subsequently, analyze using anion-exchange chromatography, gel filtration, SDS-PAGE analysis, and antigenic profiling to determine which group it belongs to.
Several expression systems can be used for recombinant production of BAbS19_I09770, each with distinct advantages:
| Expression System | Advantages | Limitations | Optimal Conditions |
|---|---|---|---|
| E. coli | High yield, rapid growth, economical | May form inclusion bodies, limited post-translational modifications | 16-25°C induction, OD₆₀₀ 0.4-0.6, 0.1-0.5mM IPTG |
| Yeast | Better folding, some post-translational modifications | Longer cultivation time, more complex media | 28-30°C, pH 5.5-6.0, methanol induction for P. pastoris |
| Baculovirus | Superior folding for complex proteins, mammalian-like modifications | Higher cost, longer production time | 27°C, high MOI for infection, 72h harvest |
| Mammalian cells | Native-like folding and modifications | Highest cost, lowest yield, technically demanding | 37°C, 5% CO₂, serum-free media preferred |
Methodological approach for selection: Conduct small-scale expression trials in multiple systems simultaneously, evaluating protein yield, purity, and functional activity through binding or structural assays .
While specific structural data for BAbS19_I09770 is limited, membrane protein topology can be predicted using computational approaches and validated experimentally:
Methodological approach for structural prediction:
Use transmembrane prediction algorithms (TMHMM, HMMTOP) to identify transmembrane helices
Apply homology modeling based on structurally characterized bacterial membrane proteins
Validate predictions experimentally through targeted cysteine labeling, protease protection assays, and epitope mapping
Determine oligomeric state through native PAGE, crosslinking studies, and analytical ultracentrifugation
The insertion mechanism likely follows either the Oxa1 pathway for segments with short translocated regions or the SecY pathway for segments with longer translocated domains .
Membrane integration of BAbS19_I09770 likely follows established biogenesis pathways for alpha-helical integral membrane proteins, which comprise approximately 25% of all proteins in organisms .
Methodological approach for studying membrane integration:
Determine whether integration follows co-translational or post-translational pathways using ribosome profiling and in vitro translation assays
Assess dependency on Oxa1 family proteins for segments with short translocated regions between transmembrane domains
Evaluate SecY channel requirements for segments with longer translocated regions
Monitor insertion kinetics using fluorescently labeled protein constructs and real-time tracking
During biogenesis, hydrophobic domains likely access the membrane through lateral gates in SecY, with downstream flanking domains entering the central channel in a looped configuration .
Isolation of native BAbS19_I09770 requires specialized techniques to maintain protein integrity:
Methodological approach for optimization:
Evaluate extraction efficiency using Western blot quantification
Assess protein homogeneity through dynamic light scattering
Validate functional integrity through lipid binding or oligomerization assays
Optimize detergent concentration to maintain native structure while maximizing yield
The presence of tightly adherent lipopolysaccharide may complicate purification and should be addressed through trichloroacetic acid extraction of cells before disruption .
Comprehensive experimental design for functional characterization requires:
Methodological approach for functional studies:
Generate gene deletion mutants (ΔBAbS19_I09770) using homologous recombination
Create complemented strains expressing wild-type and tagged versions
Develop cell invasion assays using macrophage and epithelial cell models
Establish animal infection models to assess virulence in vivo
Experimental design considerations must follow rigorous scientific methodology with appropriate controls:
| Experiment Type | Independent Variables | Dependent Variables | Controls | Statistical Analysis |
|---|---|---|---|---|
| Gene deletion effects | Bacterial strain (WT vs. ΔBAbS19_I09770) | Growth rate, invasion efficiency | Complemented strain | ANOVA with post-hoc tests |
| Protein-protein interactions | BAbS19_I09770 concentration, binding partners | Binding affinity, complex formation | Non-interacting proteins | Regression analysis |
| Host response | Protein concentration, cell type | Cytokine production, NF-κB activation | Heat-inactivated protein | t-test or Mann-Whitney |
| Animal studies | Infection dose, route | Bacterial burden, immune response | Uninfected, vector control | Survival analysis, ANOVA |
Careful experimental design must include appropriate biological and technical replicates, with attention to potential confounding factors such as lipopolysaccharide contamination .
As a membrane protein, BAbS19_I09770 likely contributes to membrane architecture and may function in:
Methodological approach for membrane function studies:
Analyze membrane permeability in wild-type versus deletion mutants using fluorescent dyes
Measure membrane potential and resistance to osmotic stress
Evaluate sensitivity to antibiotics targeting membrane integrity
Assess lipid composition and organization in presence and absence of the protein
For experimental quantification, researchers can use:
| Membrane Property | Measurement Technique | Expected Outcome if Involved in Membrane Integrity |
|---|---|---|
| Permeability | SYTOX Green uptake | Increased dye penetration in ΔBAbS19_I09770 |
| Membrane potential | DiBAC₄(3) fluorescence | Altered membrane potential in mutants |
| Antibiotic sensitivity | Minimum inhibitory concentration | Changed MIC for membrane-targeting antibiotics |
| Lipid organization | Laurdan generalized polarization | Differences in membrane fluidity and organization |
The membrane insertion mechanism of BAbS19_I09770 likely involves either the Oxa1 system for short translocated segments or the SecY channel for longer translocated regions, following the unified model for membrane protein biogenesis .
Structural characterization of BAbS19_I09770 could significantly advance vaccine development against brucellosis:
Methodological approach for structure-based vaccine design:
Determine high-resolution structure using X-ray crystallography or cryo-electron microscopy
Identify surface-exposed epitopes through computational analysis and epitope mapping
Design recombinant constructs displaying multiple immunogenic epitopes
Evaluate protective efficacy in animal models
Structural analysis workflow:
| Structural Technique | Information Obtained | Application to Vaccine Design |
|---|---|---|
| X-ray crystallography | Atomic resolution structure | Precise epitope mapping and antigen engineering |
| Cryo-electron microscopy | Native conformation in membrane | Understanding membrane context of epitopes |
| Hydrogen-deuterium exchange | Dynamic regions and solvent accessibility | Identification of flexible, exposed regions |
| Epitope mapping | Antibody binding sites | Rational design of immunogens |
During purification for structural studies, researchers must overcome challenges including detergent selection, protein stability, and maintenance of native conformation . The presence of tightly adherent lipopolysaccharide requires special consideration as it can influence structural determination and immunological properties.
Comparative analysis provides insights into evolutionary conservation and functional importance:
Methodological approach for comparative studies:
Conduct multiple sequence alignment across Brucella species
Identify conserved domains and species-specific variations
Analyze selection pressure on different protein regions
Perform cross-species complementation studies
Typical findings from comparative analysis might include:
| Brucella Species | Sequence Identity (%) | Key Amino Acid Variations | Functional Implications |
|---|---|---|---|
| B. melitensis | 95-98% | Variations in surface-exposed loops | Potential host adaptation |
| B. suis | 93-96% | Differences in transmembrane domains | Membrane integration efficiency |
| B. canis | 90-95% | Changes in charged residues | Altered electrostatic interactions |
| B. ovis | 88-93% | Insertions/deletions in certain regions | Modified protein-protein interactions |
Significant differences in amino acid composition may occur in methionine, isoleucine, tyrosine, and histidine residues, as observed in other Brucella membrane proteins . These variations could influence protein stability, membrane insertion, and immunological properties.
Generating specific antibodies against membrane proteins presents unique challenges:
Methodological approach for antibody development:
Design peptide antigens from predicted extracellular regions
Express recombinant protein fragments excluding transmembrane domains
Immunize animals with purified protein in appropriate adjuvants
Screen antibodies for specificity against native and denatured forms
Antibody development workflow:
| Antigen Type | Advantages | Limitations | Validation Methods |
|---|---|---|---|
| Synthetic peptides | Easy to produce, specific epitopes | May not recognize native conformation | ELISA, Western blot |
| Recombinant fragments | Larger epitope repertoire | Folding may differ from native protein | Immunoprecipitation, flow cytometry |
| Purified native protein | Authentic conformation | Difficult to produce, potential contaminants | Immunofluorescence, functional assays |
| DNA immunization | In vivo expression, proper folding | Lower antibody titers | Cross-reactivity testing |
The antigenic properties of BAbS19_I09770 would need to be characterized to determine if it shares antigens with other Brucella membrane proteins or if it contains unique epitopes that could be exploited for specific antibody production .
Membrane protein expression and purification face specific challenges requiring specialized approaches:
Methodological approach for optimization:
Modify expression constructs to improve folding (fusion tags, truncations)
Screen multiple detergents systematically for optimal solubilization
Evaluate protein stability under various buffer conditions
Consider alternative membrane mimetics (nanodiscs, amphipols)
Troubleshooting guide for common issues:
| Challenge | Potential Solutions | Experimental Validation |
|---|---|---|
| Poor expression | Lower induction temperature (16-20°C), use specialized strains (C41/C43) | Compare expression levels by Western blot |
| Inclusion body formation | Co-express chaperones, use solubility-enhancing tags | Analyze soluble vs. insoluble fractions |
| Detergent-induced destabilization | Screen detergent panel, add stabilizing lipids | Thermal stability assays (DSF, CPM) |
| Aggregation during purification | Include glycerol or stabilizing additives | Size exclusion chromatography profiles |
When working with outer membrane proteins like BAbS19_I09770, efficient extraction requires careful optimization of lysozyme pre-digestion and detergent selection . The presence of tightly adherent lipopolysaccharide requires special consideration, as it can influence protein stability and functional assays.
Understanding immune recognition and response to BAbS19_I09770 requires multifaceted approaches:
Methodological approach for immunological studies:
Characterize innate immune recognition through pattern recognition receptor assays
Map B-cell and T-cell epitopes using synthetic peptide libraries
Assess protective potential through vaccination and challenge studies
Evaluate inflammatory responses in cell culture and animal models
Immunological assessment framework:
| Immune Parameter | Experimental Technique | Expected Outcome for Protective Antigens |
|---|---|---|
| Innate recognition | TLR reporter assays, inflammasome activation | Activation of appropriate PRRs without excessive inflammation |
| Antibody response | ELISA, neutralization assays | High-titer, functionally relevant antibodies |
| T-cell response | ELISPOT, intracellular cytokine staining | Robust Th1-biased cellular immunity |
| Protective efficacy | Vaccination-challenge studies | Reduced bacterial burden, clinical protection |
The antigenic properties of BAbS19_I09770 would need careful characterization to determine if it shares antigens with other Brucella proteins or contains unique epitopes that could be exploited for vaccine development .
Mass spectrometry provides definitive identification and characterization of membrane proteins:
Methodological approach for proteomic analysis:
Process samples using membrane-protein-specific protocols
Perform tryptic digestion with specialized considerations for hydrophobic proteins
Analyze using LC-MS/MS with appropriate collision energies
Interpret data using database search algorithms with membrane protein parameters
Data analysis workflow:
| Analysis Step | Key Considerations | Quality Control Metrics |
|---|---|---|
| Sample preparation | Detergent removal, complete digestion | Peptide recovery, digestion efficiency |
| MS acquisition | Appropriate ionization parameters for hydrophobic peptides | Signal-to-noise ratio, mass accuracy |
| Database searching | Include post-translational modifications, sequence variants | False discovery rate, sequence coverage |
| Quantification | Label-free or isotopic labeling approaches | Coefficient of variation, statistical significance |
When identifying membrane proteins like BAbS19_I09770, researchers should expect limited peptide coverage of transmembrane regions due to hydrophobicity and poor ionization efficiency. Complementary techniques such as targeted proteomics may be necessary for comprehensive characterization.
Rigorous statistical analysis ensures reliable and reproducible research findings:
Methodological approach for statistical rigor:
Determine appropriate sample size through power analysis
Select suitable statistical tests based on data distribution
Account for multiple comparisons when analyzing complex datasets
Report effect sizes alongside p-values for meaningful interpretation
Statistical framework for common experiments:
| Experiment Type | Recommended Statistical Approach | Sample Size Considerations | Common Pitfalls |
|---|---|---|---|
| Binding assays | Non-linear regression for Kd determination | Minimum 7-8 concentrations, triplicate measurements | Assuming linear binding, ignoring non-specific binding |
| Expression comparison | ANOVA with appropriate post-hoc tests | Minimum n=3 biological replicates | Pseudoreplication, inappropriate normalization |
| Animal studies | Survival analysis, mixed effects models | Based on expected effect size (typically n≥8) | Underpowered studies, lack of randomization |
| Structural studies | Resolution statistics, validation metrics | Multiple datasets for consistency | Model bias, overfitting |
Researchers should distinguish between biological and technical replicates, report detailed statistical methods, and consider consulting with statisticians for complex experimental designs .
Recent methodological advances offer new opportunities for membrane protein research:
Methodological approach for implementing advanced techniques:
Apply single-particle cryo-electron microscopy for structure determination without crystallization
Utilize hydrogen-deuterium exchange mass spectrometry for conformational dynamics
Implement nanopore technology for single-molecule analysis
Develop proximity labeling methods for in vivo interaction mapping
Emerging technologies and applications:
| Technology | Application to BAbS19_I09770 Research | Advantages Over Traditional Methods |
|---|---|---|
| CryoEM | Native structure determination in lipid environments | No crystallization required, native lipid interactions preserved |
| Native mass spectrometry | Intact complex analysis with bound lipids | Direct measurement of protein-lipid interactions |
| Microfluidic antibody screening | Rapid identification of conformation-specific antibodies | Higher throughput, lower antigen requirements |
| CRISPR-based functional genomics | Systematic functional analysis in host-pathogen context | Genome-wide analysis of genetic interactions |
These advanced techniques could accelerate understanding of BAbS19_I09770 structure and function beyond what is possible with traditional biochemical approaches alone.
Future research directions hold promise for translational applications:
Methodological approach for translational research:
Develop structure-based vaccine candidates targeting conserved epitopes
Create diagnostic tests based on specific antibody responses
Design inhibitors targeting essential functions of the protein
Establish animal models for evaluating interventions
Research roadmap with translational milestones:
| Research Phase | Key Objectives | Methodological Approaches | Expected Timeline |
|---|---|---|---|
| Basic characterization | Structure determination, functional analysis | Structural biology, genetics, biochemistry | 1-2 years |
| Immunological profiling | Epitope mapping, immune response characterization | Immunological assays, animal models | 1-2 years |
| Vaccine development | Antigen design, formulation optimization | Recombinant protein production, adjuvant screening | 2-3 years |
| Clinical translation | Safety and immunogenicity testing | Phase I/II clinical trials | 3-5 years |
The identification of conserved epitopes across Brucella species could enable development of broadly protective vaccines, while understanding membrane protein biogenesis may reveal new antibiotic targets that disrupt bacterial membrane integrity.